Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: A systematic review and meta-analysis.

Marat FudimRichard Boortz-MarxArun GaneshNathan H WaldronYawar J QadriChetan B PatelCarmelo A MilanoAlbert Y SunJoseph P MathewJonathan P Piccini

Published in: Journal of cardiovascular electrophysiology (2017)

Early experience suggests that SGB is associated with an acute reduction in the VA burden and offers potential promise for a broader use in high-risk populations. Randomized controlled studies are needed to confirm the safety and efficacy of this therapy.

Keyphrases

liver failure
double blind
open label
left ventricular
phase iii
placebo controlled
neuropathic pain
risk factors
stem cells
machine learning
intensive care unit
mesenchymal stem cells
aortic dissection
replacement therapy
human health
deep learning
climate change
acute respiratory distress syndrome